It modulates their activation, metabolism, and cytokine release
An HS, Takegami K, Kamada H
Fe 3 O 4 nanoparticles have demonstrated efficacy as a nanoplatform for targeted drug administration, stimulus-responsive drug release, MRI diagnostics, photothermal therapy, and magnetic hyperthermia in the treatment of RA
(2009) Neutral antagonist activity of naltrexone and 6-naltrexol in nave and opioid-dependent C6 cells expressing a mu-opioid receptor
Given their multifaceted involvement in CNS pathology, a reactive form of disease-associated astrocytes has emerged as promising, but technically challenging, targets for therapeutic intervention (Liddelow et al., 2017